Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 Cream in Facial Acne Vulgaris

NCT07345390 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: KR230109 cream 0.025%
DRUG: KR230109 cream 0.05%
DRUG: Placebo

Sponsor

Jiangxi Kvvit Pharmaceutical Co., Ltd.